Purchase Order 75N93024P00882

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Certara USA Inc. for the annual provision of the Phoenix WinNonlin software.

The $17,556.00 contract has a period of performance ending on July 22, 2025 and is not designated as a set-aside award. Certara USA Inc. is a leading global technology-enabled drug development and drug safety consultancy that specializes in providing biosimulation software and expert consulting services to support drug development for biopharmaceutical clients and government agencies. Through this contract, NIAID is procuring licenses and subscriptions for Certara's Phoenix WinNonlin software, which enables federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses.

In addition to this federal contract award, Certara USA Inc. has received numerous other prime contract and subcontract awards from HHS agencies, including the Food and Drug Administration (FDA) and National Institutes of Health (NIH), as well as a cooperative agreement from the FDA's Center for Drug Evaluation and Research focused on developing machine learning approaches to population pharmacokinetic modeling.